experimental group:Fruquintinib Combined with Sintilimab and Chemotherapy

2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The First Affiliated Hospital of Anhui Medical University

Conditions

advanced pancreatic cancerpathological stage III (pIII) gastric adenocarcinoma and gastroesophageal junction adenocarcinoma after surgery.

Phase 2

A single-arm, single-center exploratory clinical study of fruquintinib combined with sintilimab and chemotherapy as first-line treatment for advanced pancreatic cancer

RecruitingChiCTR2300076306

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologyadvanced pancreatic cancer

Start: 2023-10-01Updated: 2023-10-03

Phase 4

Exploratory Clinical Study of Fruquintinib Combined with Sintilimab and Chemotherapy as Adjuvant Treatment for Stage III Gastric Cancer after Surgery

Active, not recruitingChiCTR2500114651

The First Affiliated Hospital of Anhui Medical Universitypathological stage III (pIII) gastric adenocarcinoma and gastroesophageal junction adenocarcinoma after surgery.

Start: 2026-03-24Updated: 2026-03-30